Spydergram of mean SF-36 domain scores at baseline and weeks 12 (A) and 24 (B) for sarilumab 150 mg and 200 mg+csDMARDs compared with placebo+csDMARDs.

Slides:

Advertisements

Similar presentations

A Comparative Analysis of Croatian Immigrant's and the Australian Population's subjective quality of life and self-perceived health status Gorka Vuletić.

Advertisements

Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Quality of Life After Treatment of Laryngeal.

Quality of Life in Long-term Survivors of Acute Pulmonary Embolism

Volume 42, Issue 5, Pages (May 2005)

Predictors of Health-Related Quality of Life Among Operating Engineers

Volume 160, Issue 5, Pages (November 2016)

Triangles and dotted lines are for mean values. , P <

Proportion of patients reporting scores ≥age-matched and gender-matched normative PRO values at baseline and 24 weeks in the (A) AMBITION and (B) ADACTA.

Psychosocial Correlates of Symptoms in Functional Dyspepsia

Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.

Volume 7, Issue 2, Pages (February 2015)

Clinical Epidemiology and Global Health

Lung Resection Improves the Quality of Life of Patients With Symptomatic Bronchiectasis Camilla Carlini Vallilo, MS, Ricardo Mingarini Terra, MD, PhD,

Health-Related Quality-of-Life Measures: Evidence from Tunisian Population Using the SF-12 Health Survey Moheddine Younsi, PhD Value in Health Regional.

Volume 61, Issue 5, Pages (November 2014)

The Impact of Pain Management on Quality of Life

Five-year real world outcomes of GeoForm ring implantation in patients with ischemic mitral regurgitation Tomasz A. Timek, MD, Robert L. Hooker, MD,

Volume 151, Issue 1, Pages (January 2017)

Postoperative pain after abdominal hysterectomy: a randomized, double-blind, controlled trial comparing continuous infusion vs patient-controlled intraperitoneal.

Effects of deep hypothermic circulatory arrest on outcome after resection of ascending aortic aneurysm Franz F Immer, MD, Hanna Barmettler, MD, Pascal.

Baseline Comorbidity Associated With the Short-Term Effects of Exercise Intervention on Quality of Life in the Japanese Older Population: An Observational.

Against the odds: Long-term outcome of drastic-risk cardiac surgery

Health-Related Quality of Life Outcome After On-Pump Versus Off-Pump Coronary Artery Bypass Graft Surgery: A Prospective Randomized Study Reza Motallebzadeh,

Cardiac Reoperation in Patients Aged 80 Years and Older

Responsiveness and clinically important differences for the WOMAC and SF-36 after hip joint replacement J.M. Quintana, Ph.D., A. Escobar, M.D., A. Bilbao,

Health Status Rated With the Medical Outcomes Study 36-Item Short-Form Health Survey After Spinal Cord Injury Mark J. Haran, Bonsan B. Lee, Madeleine.

Volume 44, Issue 3, Pages (March 2006)

Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement A. Escobar, M.D., J.M. Quintana, Ph.D., A. Bilbao,

Quantity of clot lysed after catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with postthrombotic morbidity Nina K. Grewal,

Long-Term Health-Related Quality of Life After Maze Surgery for Atrial Fibrillation Catharina Lundberg, MD, Anders Albåge, MD, PhD, Carina Carnlöf, RN,

Changes in evaluation indicators from baseline to 12 weeks per visit.

Laila Hellgren, MD, Elisabeth Ståhle, MD, PhD

Comparison of recovery after mitral valve repair and replacement

Impact of intensified pharmaceutical care on health related quality of life in patients with stroke in a tertiary care hospital Dilip Chandrasekhar,

Mu Qin et al. JACEP 2017;j.jacep

(A) Quality of life scores in individuals with and without constipation. (A) Quality of life scores in individuals with and without constipation. (B) Quality.

Clinical and patient-reported outcomes for patients randomised to CZP 200 mg Q2W and CZP 400 mg Q4W to week 96. Clinical and patient-reported outcomes.

Correlations between observed patient-reported outcomes and disease activity scores at week 24. Correlations between observed patient-reported outcomes.

Clinical Epidemiology and Global Health

Health-related quality of life in survivors of open ruptured abdominal aortic aneurysm repair: A matched, controlled cohort study Andrew B. Hill, MDCM,

Seth D. Crockett, Quinn K. Lippmann, Evan S. Dellon, Nicholas J

Health-Related Quality of Life in Patients Attending a Gastroenterology Outpatient Clinic: Functional Disorders Versus Organic Diseases Magnus Simrén,

Percentage of patients reporting improvements ≥MCID and NNTs to achieve an MCID in (A) PtGA, (B) pain, (C) HAQ-DI, (D) FACIT-F and (E) SF-36 domains and.

The Journal of Allergy and Clinical Immunology: In Practice

Patient-reported outcomes: proportion of patients with clinically meaningful improvements in (A) SF-36 PCS and MCS at Week 52 and Week 104*†‡ and (B) HAQ-DI.

Impact of intensified pharmaceutical care on health related quality of life in patients with stroke in a tertiary care hospital Dilip Chandrasekhar,

Probability plots JSN score at baseline (A), 10 years (B) and progression (C) for the different age groups (darkest dots: group

SF-36 domain scores at baseline and 24 weeks compared with age-matched and gender-matched normative values in the (A) AMBITION and (B) ADACTA trial populations.

Status of Patients Presently Living 9 to 13 Years After Orthotopic Heart Transplantation Roland Hetzer, Wolfgang Albert, Manfred Hummel, Miralem Pasic,

ID Dr. Natālija Nikrus, Dr. Maija Vikmane, Prof. Oskars Kalējs

Mean individual and summative SF-36 V2 scores before and 3 months after ablation. Mean individual and summative SF-36 V2 scores before and 3 months after.

Least squares mean (LSM) changes from baseline in (A) Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) Total score and (B) Ankylosing.

Patient-reported quality of life after abdominal aortic aneurysm surgery: A prospective comparison of endovascular and open repair Badr Aljabri, MD,

Relative impact of the different levels of education on the physical and mental components of SF-12 across the different chronic disorders. Relative impact.

Percentages of patients reporting improvements from baseline ≥minimum clinically important difference (MCID) and number needed to treat (NNT) in (A) patient-reported.

(A–D). (A–D). B-cell and Ig changes. Mean changes in total CD3-CD20+ B-cells (A) and immunoglobulin (Ig) subclasses levels (B-D) were measured over 24 weeks.

ACR20 response rates. ACR20 response rates. ACR20 response rates based on non-responder imputation (NRI) for the 120/Q4W, 90/Q2W and placebo groups over.

Mean Short-Form 36 (SF-36) domain scores at baseline and 6 months in patients receiving active or placebo corticosteroids, cDMARDs or TNFis. Mean Short-Form.

Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment Ralf W. Sprengers, MD, Martin Teraa,

Least squares mean changes from baseline (and 95% CIs) at month three for (A) HAQ-DI, (B) FACIT-F and (C) SF-36 physical functioning domain observed in.

Spider plot of the unstandardised SF-36v2 subscales, comparing our HCM population with the mean for the general population (aged 45–54 years). Spider plot.

Subject disposition through week 156 of treatment

Quality of life after aortic valve replacement with tissue and mechanical implants Artyom Sedrakyan, MD, Patricia Hebert, PhD, Viola Vaccarino, MD, PhD,

J. J. Smith, FRCS, A. M. Garratt, PhD, M. Guest, FRCS, R. M

Proportion of patients reporting improvements from baseline in patient-reported outcomes (PROs) ≥ the MCID at (A) 16 weeks in OPTION, (B) 12 weeks in BREVACTA.

LPA groups display vastly different outcomes.

Graphical representation of the content of the Social Role Participation Questionnaire (SRPQ), which assesses several dimensions of role participation.

Percent of patients with ASDAS inactive disease grouped by normal or elevated CRP at baseline through week 156. §p

Improvement in BASDAI score in patients with normal or elevated CRP at baseline through week 156. *p

Post hoc analysis of differences from placebo in the percentage of patients reporting improvements ≥MCID at week 24. Post hoc analysis of differences from.

Presentation transcript:

Spydergram of mean SF-36 domain scores at baseline and weeks 12 (A) and 24 (B) for sarilumab 150 mg and 200 mg+csDMARDs compared with placebo+csDMARDs relative to age- and gender-matched general population norms. Spydergram of mean SF-36 domain scores at baseline and weeks 12 (A) and 24 (B) for sarilumab 150 mg and 200 mg+csDMARDs compared with placebo+csDMARDs relative to age- and gender-matched general population norms. All scores on a scale of 0 to 100 (0=worst, 100=best). For week 12, n=181 for placebo, n=165 for sarilumab 150 mg and n=184 for sarilumab 200 mg; for week 24, n=99 for placebo, n=126 for sarilumab 150 mg and n=135 for sarilumab 200 mg. BP, Bodily Pain; GH, General Health Perceptions; MH, Mental Health; NS, not significant; PF, Physical Functioning; RE, Role Emotional; RP, Role Physical; SF, Social Functioning; VT, Vitality. Vibeke Strand et al. RMD Open 2017;3:e000416 Copyright © BMJ Publishing Group & EULAR. All rights reserved.